COVID-19

Data shows that 67% of people with mild or moderate COVID-19 infection develop long COVID, with symptoms that last more than 30 days after a positive test.

COVID-19-related anxiety can undermine or re-energize job seekers, depending on how they process it, according to new research.

A study that started by analyzing COVID-19 immunity and vaccine effectiveness in frontline workers is broadening to include children, thanks to a $15 million grant renewal from the Centers for Disease Control and Prevention.

An ancient coronavirus outbreak in East Asia could help researchers identify viruses that have caused epidemics in the past and may do so in the future.

People who contract COVID-19 even after vaccination are likely to have a lower viral load, experience a shorter infection time and have milder symptoms, new research finds.

COVID-19 has become a new threat to the coffee industry by acting as potential trigger for renewed epidemics of coffee leaf rust – the most severe coffee plant disease in the world.

A College of Medicine – Tucson assistant professor of pediatrics answers questions about COVID-19 vaccine effectiveness and the risk of side effects in children.